{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:04:34Z","timestamp":1793239474130,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41429-019-0220-x","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T04:02:29Z","timestamp":1565928149000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Synergistic enhancement of beta-lactam antibiotics by modified tunicamycin analogs TunR1 and TunR2"],"prefix":"10.1038","volume":"72","author":[{"given":"Neil P. J.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina M.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,16]]},"reference":[{"key":"220_CR1","unstructured":"CDC Centers for Disease Control and Prevention. \n                    https:\/\/www.cdc.gov\/drugresistance\/"},{"key":"220_CR2","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 2015;40:277\u201383.","journal-title":"Pharm Ther"},{"key":"220_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1021\/acsinfecdis.7b00243","volume":"4","author":"K Bush","year":"2018","unstructured":"Bush K. Game changers: new \u03b2-lactamase inhibitor combinations targeting antibiotic resistance in Gram-negative bacteria. ACS Infect Dis. 2018;4:84\u20137.","journal-title":"ACS Infect Dis."},{"key":"220_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.mib.2013.06.014","volume":"16","author":"LW Pasquina","year":"2013","unstructured":"Pasquina LW, Santa Maria JP, Walker S. Teichoic acid biosynthesis as an antibiotic target. Curr Opin Microbiol. 2013;16:531\u20137.","journal-title":"Curr Opin Microbiol."},{"key":"220_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ja.2013.100","volume":"67","author":"EW Sewell","year":"2014","unstructured":"Sewell EW, Brown ED. Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics. J Antibiot. 2014;67:43\u201351.","journal-title":"J Antibiot."},{"key":"220_CR6","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1016\/j.bmcl.2016.06.090","volume":"26","author":"MA Labroli","year":"2016","unstructured":"Labroli MA, Caldwell JP, Yang C, Lee SH, Wang H, Koseoglu S, et al. Discovery of potent wall teichoic acid early stage inhibitors. Discovery of potent wall teichoic acid early stage inhibitors. Bioorg Med Chem Lett. 2016;26:3999\u20134002.","journal-title":"Bioorg Med Chem Lett."},{"key":"220_CR7","doi-asserted-by":"publisher","first-page":"329ra32","DOI":"10.1126\/scitranslmed.aad7364","volume":"8","author":"SH Lee","year":"2016","unstructured":"Lee SH, Wang H, Labroli M, Koseoglu S, Zuck P, Mayhood T, et al. TarO-specific inhibitors of wall teichoic acid biosynthesis restore \u03b2-lactam efficacy against methicillin-resistant staphylococci. Sci Transl Med. 2016;8:329ra32.","journal-title":"Sci Transl Med."},{"key":"220_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1021\/cb100269f","volume":"6","author":"J Campbell","year":"2011","unstructured":"Campbell J, Singh AK, Santa Maria JP, Kim Y, Brown S, Swoboda JG, et al. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol. 2011;6:106\u201316.","journal-title":"ACS Chem Biol."},{"key":"220_CR9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ja.2017.101","volume":"70","author":"NPJ Price","year":"2017","unstructured":"Price NPJ, Hartman TM, Li J, Velpula KK, Naumann TA, Guda MR, et al. Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of \u03b2-lactams. J Antibiot. 2017;70:1070\u20137.","journal-title":"J Antibiot."},{"key":"220_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0014-5793(76)80657-6","volume":"69","author":"IC Hancock","year":"1976","unstructured":"Hancock IC, Wiseman G, Baddiley J. Biosynthesis of the unit that links teichoic acid to the bacterial wall: Inhibition by tunicamycin. FEBS Letts. 1976;69:75\u201380.","journal-title":"FEBS Letts"},{"key":"220_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jmb.2010.06.059","volume":"401","author":"J Kern","year":"2010","unstructured":"Kern J, Ryan C, Faull K, Schneewind O. Bacillus anthracis surface-layer proteins assemble by binding to the secondary cell wall polysaccharide in a manner that requires csaB and tagO. J Mol Biol. 2010;401:757\u201375.","journal-title":"J Mol Biol."},{"key":"220_CR12","doi-asserted-by":"publisher","first-page":"29R","DOI":"10.1093\/glycob\/cwi065","volume":"15","author":"NP Price","year":"2005","unstructured":"Price NP, Momany FA. Modeling bacterial UDP-HexNAc: polyprenol-P HexNAc-1-P transferases. Glycobiology. 2005;15:29R\u201342R.","journal-title":"Glycobiology"},{"key":"220_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.biochi.2016.06.005","volume":"127","author":"B Al-Dabbagh","year":"2016","unstructured":"Al-Dabbagh B, Olatunji S, Crouvoisier M, El Ghachi M, Blanot D, Mengin-Lecreulx D, et al. Catalytic mechanism of MraY and WecA, two paralogues of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily. Biochimie. 2016;127:249\u201357.","journal-title":"Biochimie"},{"key":"220_CR14","volume-title":"Tunicamycins","author":"G Tamura","year":"1982","unstructured":"Tamura G. Tunicamycins. Tokyo, Japan: Japan Scientific Press; 1982."},{"key":"220_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ja.2007.62","volume":"60","author":"NPJ Price","year":"2007","unstructured":"Price NPJ, Tsvetanova B. Biosynthesis of the tunicamycins: a review. J Antibiot. 2007;60:485\u201391.","journal-title":"J Antibiot."},{"key":"220_CR16","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1021\/bi00578a008","volume":"18","author":"A Heifetz","year":"1979","unstructured":"Heifetz A, Keenan RW, Elbein AD. Mechanism of action of tunicamycin on the UDP-GlcNAc: dolichyl-phosphate GlcNAc-1-phosphate transferase. Biochemistry. 1979;18:2186\u201392.","journal-title":"Biochemistry"},{"key":"220_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/glycob\/2.4.313","volume":"2","author":"KR Mclachlan","year":"1992","unstructured":"Mclachlan KR, Krag SS. Substrate specificity of N-acetylglucosamine 1-phosphate transferase activity in chinese hamster ovary cells. Glycobiology. 1992;2:313\u20139.","journal-title":"Glycobiology"},{"key":"220_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1021\/np50028a020","volume":"46","author":"K Eckardt","year":"1983","unstructured":"Eckardt K. Tunicamycins, streptovirudins, and corynetoxins, a special subclass of nucleoside antibiotics. J Nat Prod. 1983;46:544\u201350.","journal-title":"J Nat Prod."},{"key":"220_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ja.2016.49","volume":"69","author":"NPJ Price","year":"2016","unstructured":"Price NPJ, Labeda DP, Naumann TA, Vermillion KE, Bowman MJ, Berhow MA, et al. Quinovosamycins: New tunicamycin-type antibiotics in which the \u03b1, \u03b2-1\u2032,11\u2032-linked N-acetylglucosamine residue is replaced by N-acetylquinovosamine. J Antibiot. 2016;69:637\u201346.","journal-title":"J Antibiot"},{"key":"220_CR20","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.drudis.2018.05.020","volume":"23","author":"J Hering","year":"2018","unstructured":"Hering J, Dunevall E, Ek M, Br\u00e4nd\u00e9n G. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis. Drug Discov Today. 2018;23:1426\u201335.","journal-title":"Drug Discov Today"},{"key":"220_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/AAC.40.7.1640","volume":"40","author":"PE Brandish","year":"1996","unstructured":"Brandish PE, Kimura K-I, Inukai M, Southgate R, Lonsdale JT, Bugg TDH. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob Agents Chemother. 1996;40:1640\u20134.","journal-title":"Antimicrob Agents Chemother."},{"key":"220_CR22","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1021\/bi048327q","volume":"43","author":"L Xu","year":"2004","unstructured":"Xu L, Appell M, Kennedy S, Momany FA, Price NPJ. Conformational analysis of chirally deuterated tunicamycin as an active site probe of UDP-N-acetylhexosamine:polyprenol-P N-acetylhexosamine-1-P translocases. Biochemistry. 2004;43:13248\u201355.","journal-title":"Biochemistry"},{"key":"220_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nchembio.2270","volume":"13","author":"JK Hakulinen","year":"2017","unstructured":"Hakulinen JK, Hering J, Br\u00e4nd\u00e9n G, Chen H, Snijder A, Ek M, et al. MraY-antibiotic complex reveals details of tunicamycin mode of action. Nat Chem Biol. 2017;13:265\u20137.","journal-title":"Nat Chem Biol."},{"key":"220_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1126\/science.1236501","volume":"341","author":"BC Chung","year":"2013","unstructured":"Chung BC, Zhao J, Gillespie RA, Kwon D-Y, Guan Z, Hong J, et al. Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis. Science. 2013;341:1012\u20136.","journal-title":"Science"},{"key":"220_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature17636","volume":"533","author":"BC Chung","year":"2016","unstructured":"Chung BC, Mashalidis EH, Tanino T, Kim M, Matsuda A, Hong J, et al. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis. Nature. 2016;533:557\u201360.","journal-title":"Nature"},{"key":"220_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41594-018-0031-y","volume":"25","author":"J Yoo","year":"2018","unstructured":"Yoo J, Mashalidis EH, Kuk ACY, Ichikawa S, Lee S-Y. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat Struct Mol Biol 2018;25:217\u201324.","journal-title":"Nat Struct Mol Biol"},{"key":"220_CR27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/glycob\/cwx064","volume":"27","author":"V Lukose","year":"2017","unstructured":"Lukose V, Walvoort MTC, Imperiali B. Bacterial phosphoglycosyl transferases: initiators of glycan biosynthesis at the membrane interface. Glycobiology. 2017;27:820\u201333.","journal-title":"Glycobiology"},{"key":"220_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbagen.2009.03.030","volume":"1790","author":"MB Jones","year":"2009","unstructured":"Jones MB, Rosenberg JN, Betenbaugh MJ, Krag SS. Structure and synthesis of polyisoprenoids used in N-glycosylation across the three domains of life. Biochim Biophys Acta. 2009;1790:485\u201394.","journal-title":"Biochim Biophys Acta."},{"key":"220_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2010.06.001","volume":"142","author":"V Cantagrel","year":"2010","unstructured":"Cantagrel V, Lefeber DJ, Ng BG, Guan Z, Silhavy JL, Bielas SL, et al. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 2010;142:203\u201317.","journal-title":"Cell"},{"key":"220_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/22.1.5","volume":"1988","author":"GN Rolinson","year":"1988","unstructured":"Rolinson GN. The influence of 6-aminopenicillanic acid on antibiotic development. J Antimicrob Chemother. 1988;1988:5\u201314.","journal-title":"J Antimicrob Chemother."},{"key":"220_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00253-003-1274-y","volume":"61","author":"RP Elander","year":"2003","unstructured":"Elander RP. Industrial production of beta-lactam antibiotics. Appl Microbiol Biotechnol. 2003;61:385\u201392.","journal-title":"Appl Microbiol Biotechnol."},{"key":"220_CR32","unstructured":"Petri Jr WA. Penicillins, cephalosporins, and other beta-lactam antibiotics. In: Brunton L Chabner, B Knollman, editors. Goodman and Gilman\u2019s the pharmacological basis of therapeutics, (12th ed.). New York: McGraw Hill Professional; 2011. p. 1477\u2013504."},{"key":"220_CR33","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1128\/AAC.45.12.3355-3361.2001","volume":"45","author":"L Poirel","year":"2001","unstructured":"Poirel L, Naas T, Le Thomas I, Amal K, Bingen E, Nordmann P. CTX-M-type extended-spectrum \u03b2-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother. 2001;45:3355\u201361.","journal-title":"Antimicrob Agents Chemother."},{"key":"220_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/AAC.35.1.14","volume":"35","author":"M Limbert","year":"1991","unstructured":"Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, et al. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR llyV), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1991;35:14\u20139.","journal-title":"Antimicrob Agents Chemother."},{"key":"220_CR35","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1039\/C8MD00342D","volume":"17","author":"KHME Tehrani","year":"2018","unstructured":"Tehrani KHME, Martin NI. \u03b2-lactam\/\u03b2-lactamase inhibitor combinations: an update. Medchemcomm. 2018;17:1439\u201356.","journal-title":"Medchemcomm"},{"key":"220_CR36","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1016\/j.bmcl.2016.08.036","volume":"26","author":"S-W Yang","year":"2016","unstructured":"Yang S-W, Pan J, Yang C, Labroli M, Pan W, Caldwell J, et al. Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus. Bioorg Med Chem Lett. 2016;26:4743\u20137.","journal-title":"Bioorg Med Chem Lett."},{"key":"220_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/acsmedchemlett.7b00285","volume":"8","author":"MA Foxley","year":"2018","unstructured":"Foxley MA, Wright SN, Lam AK, Friedline AW, Strange SJ, Xiao MT, et al. Targeting wall teichoic acid in situ with branched polyethylenimine potentiates \u03b2-lactam efficacy against MRSA. ACS Med Chem Lett. 2018;8:1083\u20138.","journal-title":"ACS Med Chem Lett."},{"key":"220_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.taap.2014.12.019","volume":"283","author":"H Wang","year":"2015","unstructured":"Wang H, Wang X, Ke ZJ, Comer AL, Xu M, Frank JA, et al. Tunicamycin-induced unfolded protein response in the developing mouse brain. Toxicol Appl Pharmacol. 2015;283:157\u201367.","journal-title":"Toxicol Appl Pharmacol."},{"key":"220_CR39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1751-0813.1987.tb09689.x","volume":"64","author":"MV Jago","year":"1987","unstructured":"Jago MV, Culvenor CC. Tunicamycin and corynetoxin poisoning in sheep. Aust Vet J. 1987;64:232\u20135.","journal-title":"Aust Vet J."},{"key":"220_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7164\/antibiotics.33.614","volume":"33","author":"S Horikawa","year":"1980","unstructured":"Horikawa S, Ogawara H. Penicillin-binding proteins in Bacillus subtilis. The effects on penicillin-binding proteins and the antibacterial activities of beta-lactams. J Antibiot. 1980;33:614\u20139.","journal-title":"J Antibiot."},{"key":"220_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/mmi.13765","volume":"106","author":"J Sassine","year":"2017","unstructured":"Sassine J, Xu M, Sidiq KR, Emmins R, Errington J, Daniel RA. Functional redundancy of division specific penicillin-binding proteins in Bacillus subtilis. Mol Microbiol. 2017;106:304\u201318.","journal-title":"Mol Microbiol."},{"key":"220_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tim.2018.06.005","volume":"27","author":"TJ Foster","year":"2019","unstructured":"Foster TJ. Can \u03b2-lactam antibiotics be resurrected to combat MRSA? Trends Microbiol. 2019;27:26\u201338.","journal-title":"Trends Microbiol."},{"key":"220_CR43","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1111\/1462-2920.12206","volume":"15","author":"MC Lages","year":"2013","unstructured":"Lages MC, Beilharz K, Morales Angeles D, Veening JW, Scheffers DJ. The localization of key Bacillus subtilis penicillin binding proteins during cell growth is determined by substrate availability. Environ Microbiol. 2013;15:3272\u201381.","journal-title":"Environ Microbiol."},{"key":"220_CR44","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ja.2017.141","volume":"70","author":"NPJ Price","year":"2017","unstructured":"Price NPJ, Jackson MA, Vermillion KE, Li J, Yu B. Selective catalytic hydrogenation of the N-acyl and uridyl double bonds in the tunicamycin family of protein N-glycosylation inhibitors. J Antibiot. 2017;70:1122\u20138.","journal-title":"J Antibiot."},{"key":"220_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/abio.2000.4952","volume":"289","author":"BC Tsvetanova","year":"2001","unstructured":"Tsvetanova BC, Price NPJ. Liquid chromatography-electrospray mass spectrometry of tunicamycin-type antibiotics. Anal Biochem. 2001;289:147\u201356.","journal-title":"Anal Biochem."},{"key":"220_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10886-011-9950-3","volume":"37","author":"PF Dowd","year":"2011","unstructured":"Dowd PF, Berhow MA, Johnson ET. Differential activity of multiple saponins against omnivorous insects with varying feeding preferences. J Chem Ecol. 2011;37:443\u20139.","journal-title":"J Chem Ecol."},{"key":"220_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.chembiol.2014.11.006","volume":"22","author":"V Singh","year":"2015","unstructured":"Singh V, Brecik M, Mukherjee R, Evans JC, Svetlikova Z, Blasko J, et al. The complex mechanism of antimycobacterial action of 5-fluorouracil. Chem Biol. 2015;22:63\u201375.","journal-title":"Chem Biol."},{"key":"220_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/acsinfecdis.6b00102","volume":"3","author":"V Singh","year":"2017","unstructured":"Singh V, Donini S, Pacitto A, Sala C, Hartkoorn RC, Dhar N, et al. The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis. ACS Infect Dis. 2017;3:5\u201317.","journal-title":"ACS Infect Dis."},{"key":"220_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.","journal-title":"J Antimicrob Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0220-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-019-0220-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:32:15Z","timestamp":1684618335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0220-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,16]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1038\/s41429-019-0220-x","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,16]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}